Streetbeat News

Stock Prices

BPMC

Blueprint Medicines (NASDAQ:BPMC) is set to release its latest quarterly earnings report on October 26, 2023. Analysts estimate an earnings per share (EPS) of $-2.37. The company's past performance shows a pattern of share price drops following earnings reports, even when beating estimates. Shares are currently trading at $46.23, down 9.16% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

October 25, 2023 | 3:01 pm

AOS

A.O. Smith (NYSE:AOS) is set to release its quarterly earnings report on October 26, 2023. Analysts estimate an earnings per share (EPS) of $0.80. The company's past performance shows a pattern of beating EPS estimates, but this has sometimes been followed by a drop in share price. The stock is currently trading at $66.64 and has seen a 27.16% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

October 25, 2023 | 3:01 pm

VC

Visteon (NASDAQ:VC) is set to release its quarterly earnings report on October 26, 2023. Analysts estimate an earnings per share (EPS) of $1.98. The company's past performance shows a trend of share price drops following earnings misses. Visteon's shares were trading at $124.88 as of October 24, with a 0.41% decrease over the last 52-week period.

Portfolio Pulse from Benzinga Insights

October 25, 2023 | 3:01 pm

LII

Lennox Intl (NYSE:LII) is set to release its latest quarterly earnings report on October 26, 2023. Analysts estimate an earnings per share (EPS) of $4.75. The company's past performance shows a trend of beating EPS estimates, which has typically resulted in a share price increase. The stock is currently trading at $345.51, up 48.62% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

October 25, 2023 | 3:01 pm

MANU

Manchester United (NYSE:MANU) is set to release its latest quarterly earnings report on October 26, 2023. Analysts estimate an earnings per share (EPS) of $-0.13. The company's past performance shows a mixed impact on the share price post-earnings release. The stock is currently trading at $17.78 and has seen a 33.48% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

October 25, 2023 | 3:01 pm

ORI

Old Republic Intl (NYSE:ORI) is set to release its latest quarterly earnings report on October 26, 2023. Analysts estimate an earnings per share (EPS) of $0.62. The company's past performance shows a trend of beating EPS estimates, which has generally led to an increase in share price. The stock is currently trading at $26.92 and has seen a 17.12% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

October 25, 2023 | 3:00 pm

SONN

Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) shares are trading lower by 27.6% after the company announced the pricing of a public offering involving 2,843,750 shares of common stock or pre-funded warrants, along with investor warrants allowing the purchase of up to 5,687,500 shares of common stock. The combined offering price is $1.60 per share, totaling approximately $4.55 million in gross proceeds before expenses. The funds raised will be utilized for research and development, including clinical trials, as well as general corporate purposes.

Portfolio Pulse from Henry Khederian

October 25, 2023 | 3:00 pm

LDOUSD

Cryptocurrency Lido DAO (CRYPTO: LDO) has seen a price increase of 6.58% over the past 24 hours to $1.92. Over the past week, LDO has risen by over 26.0%, moving from $1.5 to its current price. The trading volume for the coin has increased 133.0% over the past week, while the overall circulating supply of the coin has decreased 1.75%. The current market cap ranking for LDO is #33 at $1.66 billion.

Portfolio Pulse from Benzinga Insights

October 25, 2023 | 3:00 pm

LINKUSD

Chainlink's (CRYPTO: LINK) price has risen 8.65% to $11.15 in the past 24 hours, continuing its positive trend over the past week with a 50.0% gain. The coin's trading volume has climbed 698.0% over the past week, moving in tandem with the overall circulating supply of the coin, which has increased 1.29%. The current market cap ranking for LINK is #13 at $6.21 billion.

Portfolio Pulse from Benzinga Insights

October 25, 2023 | 3:00 pm

SONN

Sonnet BioTherapeutics has announced the pricing of a $4.55 million underwritten public offering, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 2:59 pm